Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth.

Abstract:

:Rodent biliary glycoprotein (Bgp), also known as C-CAM, has recently been shown to function as a tumor suppressor in colon, prostate, and bladder cancers. This glycoprotein is a member of the carcinoembryonic antigen family and is one of the only proteins in this family to encode either a long (71-73 amino acids) or short (10 amino acids) cytoplasmic domain. We and others have shown that the growth-inhibitory properties of Bgp depend upon the expression of its long cytoplasmic domain. However, the two Bgp isoforms normally coexist in most cell types surveyed; the longer variant is usually present in lower amounts than the shorter one. In this study, we have examined the in vitro and in vivo growth properties of both mouse Bgp variants separately and in combination. To determine the physiologically relevant expression levels and ratios of the two Bgp variants, we have quantified the amount of the longer variant in normal colonic epithelial cells and showed that it constitutes 15-20% of total Bgp expressed in this tissue. To mimic the in vivo situation, we have generated double transfectant cell lines expressing the longer and shorter Bgp isoforms coordinately in tumorigenic CT51 mouse colonic carcinoma cells and demonstrated that the longer Bgp isoform exhibits a dominant tumor growth inhibition phenotype over that of the shorter variant within physiological levels of expression of Bgp. Unexpectedly, significant overexpression of the longer Bgp isoform alone led to reversal of the tumor inhibition phenotype. These results, therefore, suggest that there may be a limiting threshold of Bgp expression or Bgp-associating proteins mediating the tumor inhibition phenotype.

journal_name

Cancer Res

journal_title

Cancer research

authors

Turbide C,Kunath T,Daniels E,Beauchemin N

subject

Has Abstract

pub_date

1997-07-01 00:00:00

pages

2781-8

issue

13

eissn

0008-5472

issn

1538-7445

journal_volume

57

pub_type

杂志文章
  • Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.

    abstract::To examine genetic instability during carcinogenesis, we screened 171 carcinomas of the breast, liver, proximal colon, stomach, pancreas, uterine cervix, and ovary for replication error at four microsatellite marker loci on chromosome 2, 3, and 17. A significantly high incidence of genetic instability was observed in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Han HJ,Yanagisawa A,Kato Y,Park JG,Nakamura Y

    更新日期:1993-11-01 00:00:00

  • Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies.

    abstract::Interleukin 4, a T cell-derived 20-kDa glycoprotein, plays an important role in regulating the immune response of B cells, T cells, and macrophages against infections and malignant cells. For this reason recombinant human interleukin 4 (rhIL-4) has entered early clinical trials in cancer patients. In the present study...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Topp MS,Papadimitriou CA,Eitelbach F,Koenigsmann M,Oelmann E,Koehler B,Oberberg D,Reufi B,Stein H,Thiel E

    更新日期:1995-05-15 00:00:00

  • Overexpression of DNA-binding protein B gene product in breast cancer as detected by in vitro-generated combinatorial human immunoglobulin libraries.

    abstract::Molecules differentially expressed or overexpressed by malignant cells can serve in detecting and tracking of tumor. Additionally, they potentially can be applied in histologic-specific antitumor therapy. Few breast cancer-associated candidate molecules have been identified. Here we describe the use of combinatorial i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rubinstein DB,Stortchevoi A,Boosalis M,Ashfaq R,Guillaume T

    更新日期:2002-09-01 00:00:00

  • Human ovarian carcinoma cells maintained on extracellular matrix versus plastic.

    abstract::The ability of culture dishes coated with an extracellular matrix (ECM) to act as a suitable substrate for human ovarian carcinoma cells in vitro has been examined. The plating efficiency on ECM was 30 to 80% (dispersed tumor cells from solid tumor tissue and effusions) with active proliferation of tumor cells being o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crickard K,Crickard U,Yoonessi M

    更新日期:1983-06-01 00:00:00

  • Lymphoid cell subpopulations infiltrating into autologous rat tumors undergoing rejection.

    abstract::Lymphoid cell subpopulations infiltrating into autografts of methylcholanthrene-induced sarcomas in rats immunized with autologous tumor cells were identified in terms of immunohistochemical and cytofluorographic techniques using various monoclonal antibodies raised against different classes of rat lymphohemopoietic c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ishii Y,Matsuura A,Takami T,Uede T,Ibayashi Y,Uede T,Imamura M,Kikuchi K,Kikuchi Y

    更新日期:1984-09-01 00:00:00

  • Structural heterogeneity of a human melanoma-associated antigen.

    abstract::The biosynthesis, structure, and topology of a melanoma-associated antigen, previously defined with the monoclonal antibody NKI/C-3 was studied. A polyclonal rabbit antiserum was raised against the antigen with a broader reactivity than the previously used monoclonal antibody NKI/C-3. The antigen was shown to consist ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gruters RA,Calafat J,Vennegoor CJ,Jansen H,Ploegh HL

    更新日期:1989-01-15 00:00:00

  • Comparison of the structural and cytotoxic activity of novel 2,5-bis(carboethoxyamino)-3,6-diaziridinyl-1,4-benzoquinone analogues.

    abstract::Eight analogues of 2,5-bis(carboethoxyamino)-3,6-diaziridinyl-1,4-benzoquinone have been synthesized and tested for cytotoxicity against four different leukemic and lymphomic cell lines. For K562 and BSM cells, the toxicity could be correlated with the ease of reduction of the compounds as determined by the one-electr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dzielendziak A,Butler J,Hoey BM,Lea JS,Ward TH

    更新日期:1990-04-01 00:00:00

  • Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.

    abstract::Cancer cell motility has been associated with metastatic potential of sublines of the Dunning R-3227 rat prostatic adenocarcinoma model. However, three sublines of high motility lacked the capacity for metastasis. In all previous works, motility has been studied upon plastic and only upon attached cells at least 18 h ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mohler JL,Levy F,Sharief Y

    更新日期:1991-12-15 00:00:00

  • Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line).

    abstract::Alkaline phosphatase activity in human endometrial cancer cells of the estrogen-responsive Ishikawa line was markedly stimulated (3-20-fold in 4 days) by estrogens, 5 alpha-dihydrotestosterone, and dehydroepiandrosterone but not by testosterone, medroxyprogesterone acetate, glucocorticoids, several peptide hormones, p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Holinka CF,Hata H,Kuramoto H,Gurpide E

    更新日期:1986-06-01 00:00:00

  • DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.

    abstract::Hypomethylation of CpG dinucleotides in genomic DNA was one of the first somatic epigenetic alterations discovered in human cancers. DNA hypomethylation is postulated to occur very early in almost all human cancers, perhaps facilitating genetic instability and cancer initiation and progression. We therefore examined t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6088

    authors: Yegnasubramanian S,Haffner MC,Zhang Y,Gurel B,Cornish TC,Wu Z,Irizarry RA,Morgan J,Hicks J,DeWeese TL,Isaacs WB,Bova GS,De Marzo AM,Nelson WG

    更新日期:2008-11-01 00:00:00

  • Vascular endothelial growth factor--a positive and negative regulator of tumor growth.

    abstract::Over the past decade, the well-documented role of vascular endothelial growth factor (VEGF) in tumor angiogenesis has led it to become one of the leading therapeutic targets for the treatment of cancer. Emerging evidence from genetically modified animal models, however, suggests that elevated levels of VEGF, or a proa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3592

    authors: Vecchiarelli-Federico LM,Cervi D,Haeri M,Li Y,Nagy A,Ben-David Y

    更新日期:2010-02-01 00:00:00

  • Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.

    abstract::Anticancer drug resistance results from selective pressure of chemotherapy, together with mutations or epigenetic changes that make cells refractory to treatment. In cancer cells, we report that gene expression associated with vesicle shedding correlates with chemosensitivity profiles. Experiments with doxorubicin and...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shedden K,Xie XT,Chandaroy P,Chang YT,Rosania GR

    更新日期:2003-08-01 00:00:00

  • Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

    abstract::Immunization to multiple defined tumor antigens for specific immune therapy of human cancer has thus far proven difficult. Eighteen HLA A*0201(+) patients with metastatic melanoma received injections s.c. of CD34(+)progenitor-derived autologous dendritic cells (DCs), which included Langerhans cells. DCs were pulsed wi...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Banchereau J,Palucka AK,Dhodapkar M,Burkeholder S,Taquet N,Rolland A,Taquet S,Coquery S,Wittkowski KM,Bhardwaj N,Pineiro L,Steinman R,Fay J

    更新日期:2001-09-01 00:00:00

  • Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.

    abstract::One of the major limitations of tumor-specific vaccination is the generation of antigen-loss variants that are able to escape the immune response elicited by a monoantigenic peptide epitope. Here, we report the identification of a new HLA-B*3701-restricted epitope shared by four different members of the MAGE family. P...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tanzarella S,Russo V,Lionello I,Dalerba P,Rigatti D,Bordignon C,Traversari C

    更新日期:1999-06-01 00:00:00

  • Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma.

    abstract::Data on biodistribution and pharmacokinetics of Na2B12H11SH are few and lack in standardization. This study comprises a uniform series of 10 patients with glioblastoma administered Na2B12H11SH i.v. 24 h before surgery at a dose level used in earlier therapeutical trials (75 mg/kg body weight). Boron concentrations in ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Haselsberger K,Radner H,Pendl G

    更新日期:1994-12-15 00:00:00

  • Siah proteins: novel drug targets in the Ras and hypoxia pathways.

    abstract::The Siah (seven in absentia homolog) family of RING-domain proteins are components of ubiquitin ligase complexes, targeting proteins for proteasomal degradation. Siah family members have been reported to function in Ras, estrogen, DNA-damage, and hypoxia response pathways. Although earlier reports implicated Siah prot...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-09-1676

    authors: House CM,Möller A,Bowtell DD

    更新日期:2009-12-01 00:00:00

  • G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.

    abstract::Cultured human T-cell leukemia lymphocytes have enhanced sensitivity to growth inhibition by deoxyadenosine. We have used flow cytometry to investigate the mechanism of deoxyadenosine toxicity in cultured T-leukemic cells. Comparative studies on deoxyadenosine-resistant Epstein-Barr virus-transformed B-lymphocyte cell...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fox RM,Kefford RF,Tripp EH,Taylor IW

    更新日期:1981-12-01 00:00:00

  • mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.

    abstract::The underlying mechanism regulating the expression of the cancer stem cell/tumor-initiating cell marker CD133/prominin-1 in cancer cells remains largely unclear, although knowledge of this mechanism would likely provide important biological information regarding cancer stem cells. Here, we found that the inhibition of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1289

    authors: Matsumoto K,Arao T,Tanaka K,Kaneda H,Kudo K,Fujita Y,Tamura D,Aomatsu K,Tamura T,Yamada Y,Saijo N,Nishio K

    更新日期:2009-09-15 00:00:00

  • Identification of somatomedin-like polypeptides produced by mammary tumors of BALB/c mice.

    abstract::A transplantable mammary tumor derived from an outgrowth of nodule-like alveolar lesions induced by 7,12-dimethylbenz[a]anthracene in cultures of whole mammary gland was shown to produce a family of somatomedin-like polypeptides when cultured in vitro. Minced mammary tumor tissue as well as monolayer cultures of tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Knauer DJ,Iyer AP,Banerjee MR,Smith GL

    更新日期:1980-12-01 00:00:00

  • Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.

    abstract::Human malignant mesothelioma of the pleura was successfully transplanted s.c. into athymic nude mice and grew as a solid neoplastic mass. Tumor growth resulted in death of the animals between 98 and 161 days after implantation. Minced samples of the growing tumor were propagated as a malignant peritoneal effusion. Ani...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reale FR,Griffin TW,Compton JM,Graham S,Townes PL,Bogden A

    更新日期:1987-06-15 00:00:00

  • Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin.

    abstract::We performed a phase I trial of cyclosporin A (CsA) in combination with doxorubicin (dox) to determine the maximally tolerated dose (MTD) of the combination in man, to define the quantitative and qualitative toxicities of the combination, and to determine the pharmacokinetics of the two drugs when used together. CsA w...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Erlichman C,Moore M,Thiessen JJ,Kerr IG,Walker S,Goodman P,Bjarnason G,DeAngelis C,Bunting P

    更新日期:1993-10-15 00:00:00

  • Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients.

    abstract::The expression of many genes is altered in colon cancer, but the roles of these genes in carcinogenesis are unclear. Using real-time quantitative PCR, we demonstrated that several genes previously implicated in human colon cancer undergo altered expression in the APC(min) mouse adenomatous polyp, a precursor of cancer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3264

    authors: Chen LC,Hao CY,Chiu YS,Wong P,Melnick JS,Brotman M,Moretto J,Mendes F,Smith AP,Bennington JL,Moore D,Lee NM

    更新日期:2004-05-15 00:00:00

  • Ultrasonically activated chemotherapeutic drug delivery in a rat model.

    abstract::Systemic delivery of anticancer agents is accompanied by many unwanted side effects that can be mitigated by encapsulation of antineoplastic agents. However, encapsulation necessitates a technique for controlled delivery to the cancerous tissue. We have developed a novel drug delivery system that releases drug from st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nelson JL,Roeder BL,Carmen JC,Roloff F,Pitt WG

    更新日期:2002-12-15 00:00:00

  • Glucocorticoid receptor monoclonal antibodies define the biological action of RU 38486 in intact B16 melanoma cells.

    abstract::The mechanism of action of the synthetic glucocorticoid antagonist, RU 38486, has yet to be completely elucidated. Although RU 38486 is a potent antiglucocorticoid in vivo, several studies have indicated that it has some agonist activities in vitro, such as high-affinity steroid binding to the receptor, activation, an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lindemeyer RG,Robertson NM,Litwack G

    更新日期:1990-12-15 00:00:00

  • Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.

    abstract::In an attempt to better understand breast tumors sensitivity or resistance to anticancer drugs, the main drug-metabolizing enzyme systems were evaluated in both breast tumors and their corresponding peritumoral tissues in 12 patients. The following enzymes were assayed by Western blot: cytochromes P-450 (1A1/A2, 2B1/B...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Albin N,Massaad L,Toussaint C,Mathieu MC,Morizet J,Parise O,Gouyette A,Chabot GG

    更新日期:1993-08-01 00:00:00

  • Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells.

    abstract::Mounting evidence suggests a role for matrix metalloproteinase (MMP)-2 in the malignant progression of breast cancer cells. We showed previously that H-Ras, but not N-Ras, induced invasion of MCF10A human breast epithelial cells through Rac-MKK3/6-p38 pathway resulted in MMP-2 up-regulation. Activation of p38 pathway ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1461

    authors: Song H,Ki SH,Kim SG,Moon A

    更新日期:2006-11-01 00:00:00

  • Retinoid feeding, hormone inhibition, and/or immune stimulation and the genesis of carcinogen-induced rat mammary carcinomas.

    abstract::Female Sprague-Dawley rats were treated at 53 days of age with a single intubation of 7,12-dimethylbenzanthracene (DMBA). Three days after carcinogen treatment, the animals were treated with retinyl acetate (RA) (at 3 dietary levels), hormone inhibition (HI) [tamoxifen (1-rho-beta-dimethylaminoethoxyphenyl-trans-1,2-d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Welsch CW,DeHoog JV

    更新日期:1983-02-01 00:00:00

  • Colony growth in agar by human melanoma cells.

    abstract::Colony-forming capacity of human melanoma cells was investigated in five established cell lines and isolated cells from seven metastatic or recurrent tumors. A single-cell suspension was added to 0.3% agar medium, and colonies were observed over 7 to 21 days. With the five cell lines, colony formation occurred in all ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Asano S,Riglar C

    更新日期:1981-03-01 00:00:00

  • Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer.

    abstract::The signaling pathways that mediate the development of pancreatic ductal adenocarcinoma (PDAC) downstream of mutant Kras remain incompletely understood. Here, we focus on ribosomal protein S6 (rpS6), an mTOR effector not implicated previously in cancer. Phosphorylation of rpS6 was increased in pancreatic acinar cells ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2014

    authors: Khalaileh A,Dreazen A,Khatib A,Apel R,Swisa A,Kidess-Bassir N,Maitra A,Meyuhas O,Dor Y,Zamir G

    更新日期:2013-03-15 00:00:00

  • Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy.

    abstract::Preclinical and clinical development of agents that inhibit cell-cycle progression have brought an understanding of the feasibility of targeting various cell-cycle regulators in patients with cancer. Small molecule inhibitors targeting key proteins that participate in cell-cycle progression including the cyclin-depend...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-17-2782

    authors: Mills CC,Kolb EA,Sampson VB

    更新日期:2018-01-15 00:00:00